Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 3—March 2017

Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007–2012

Cara D. VarleyComments to Author , Jennifer H. Ku, Emily Henkle, Sean D. Schafer, and Kevin L. Winthrop
Author affiliations: Tulane University, New Orleans, Louisiana, USA (C.D. Varley); Oregon Health & Science University, Portland, Oregon, USA (C.D. Varley, J.H. Ku, E. Henkle, K.L. Winthrop); Oregon Department of Human Services, Portland (C.D. Varley, E. Henkle, S.D. Schafer)

Main Article

Table 2

Incidence of disseminated nontuberculous mycobacterial disease, by CD4 count closest to diagnosis date, Oregon, USA, 2007–2012*

CD4 count, cells/mm3
<50, n = 677
50–100, n = 784
101–200, n = 1,697
>200, n = 5,827
Incidence/100,000 person-years (95% CI) 5,300 (3,360–7,950) 950 (310–2,210) 60 (0–310) 10 (0–30)

*n values indicate no. patients with >1 CD4 count in specified category.

Main Article

Page created: February 17, 2017
Page updated: February 17, 2017
Page reviewed: February 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.